How To Manage Your 340B Program Without Hiring More Staff

November 9, 2022340B, 340B ESP, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Meds To Beds, Outpatient Tracking, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Pharmacy

Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions VytlOne recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A VytlOne pharmacist since 2018, she … Read More

What Is Your ROI Potential With An Optimized 340B Program?

October 24, 2022340B, 340B ESP, Contract Pharmacy, Overview, Patient Eligibility, Specialty Drugs, Specialty Pharmacy

Introducing VytlOne’s 340B Program ROI Calculator The 340B program has often been described, and with good reason, as a black box. There are dozens of factors impacting an individual hospital’s relative success or failure in generating positive returns from a program. VytlOne has optimized dozens of 340B programs — generating over $500 million in savings … Read More

Best Practices Every 340B Hospital Needs To Know

April 1, 2022340B, Audit, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Covered Entities, Meds To Beds, Overview, Patient Eligibility, Requirements, Specialty Pharmacy, Specialty Pharmacy

POST OUTLINE 1) Introduction  Overview: Savings potential of a 340B program. 340B savings generated by VytlOne ($300M in 2025 alone. 2) Tips for maintaining 340B Program Compliance Why so many 340B eligible hospitals don’t have programs. 340B compliance checklist and additional resources. Definition of 340B Duplicate Discounts. 3) Patient eligibility, and who qualifies for 340B … Read More

What is 340B Double-Dipping, and How Can You Avoid It?

March 25, 2022340B, Compliance, Contract Pharmacy, Covered Entities, Patient Eligibility, Registration, Requirements

The 340B drug pricing program allows eligible providers to replenish prescriptions to eligible patients at significantly reduced pricing, and bill normal market rates for those prescriptions —helping the entities fill revenue gaps that are inherent to their business models. That said, the program does not allow eligible providers to take advantage of 340B discounts and … Read More